• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDE4D 促进 BRAF 突变型黑色素瘤中 FAK 介导的细胞侵袭。

PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

机构信息

INSERM, U976, Centre de Recherche sur la Peau, F-75010 Paris, France.

Univ Paris Diderot, Sorbonne Paris Cité, UMR 976, F-75010 Paris, France.

出版信息

Oncogene. 2017 Jun 8;36(23):3252-3262. doi: 10.1038/onc.2016.469. Epub 2017 Jan 16.

DOI:10.1038/onc.2016.469
PMID:28092671
Abstract

The cyclic AMP (cAMP) signaling pathway is critical in melanocyte biology for regulating differentiation. It is downregulated by phosphodiesterase (PDE) enzymes, which degrade cAMP itself. In melanoma evidence suggests that inhibition of the cAMP pathway by PDE type 4 (PDE4) favors tumor progression. For example, in melanomas harboring RAS mutations, the overexpression of PDE4 is crucial for MAPK pathway activation and proliferation induced by oncogenic RAS. Here we showed that PDE4D is overexpressed in BRAF-mutated melanoma cell lines, constitutively disrupting the cAMP pathway activation. PDE4D promoted melanoma invasion by interacting with focal adhesion kinase (FAK) through the scaffolding protein RACK1. Inhibition of PDE4 activity or inhibition of PDE4D interaction with FAK reduced invasion. PDE4D expression is increased in patients with advanced melanoma and PDE4D-FAK interaction is detectable in situ in metastatic melanoma. Our study establishes the role of PDE4D in BRAF-mutated melanoma as regulator of cell invasion, and suggests its potential as a target for preventing metastatic dissemination.

摘要

环腺苷酸 (cAMP) 信号通路在黑素细胞生物学中对于调节分化至关重要。它被磷酸二酯酶 (PDE) 酶下调,这些酶本身降解 cAMP。在黑色素瘤中,有证据表明 PDE4 型(PDE4)抑制 cAMP 通路有利于肿瘤进展。例如,在携带 RAS 突变的黑色素瘤中,PDE4 的过度表达对于由致癌性 RAS 诱导的 MAPK 通路激活和增殖至关重要。在这里,我们表明 PDE4D 在 BRAF 突变的黑色素瘤细胞系中过表达,持续破坏 cAMP 通路的激活。PDE4D 通过支架蛋白 RACK1 与粘着斑激酶 (FAK) 相互作用促进黑色素瘤侵袭。抑制 PDE4 活性或抑制 PDE4D 与 FAK 的相互作用可降低侵袭性。晚期黑色素瘤患者中 PDE4D 的表达增加,并且在转移性黑色素瘤中可在原位检测到 PDE4D-FAK 相互作用。我们的研究确立了 PDE4D 在 BRAF 突变的黑色素瘤中的作用作为细胞侵袭的调节剂,并表明其作为预防转移扩散的潜在靶点。

相似文献

1
PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.PDE4D 促进 BRAF 突变型黑色素瘤中 FAK 介导的细胞侵袭。
Oncogene. 2017 Jun 8;36(23):3252-3262. doi: 10.1038/onc.2016.469. Epub 2017 Jan 16.
2
ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.ERK 和 PDE4 合作诱导黑色素瘤中 RAF 同工型转换。
Nat Struct Mol Biol. 2011 May;18(5):584-91. doi: 10.1038/nsmb.2022. Epub 2011 Apr 10.
3
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.磷酸二酯酶-4通过与 HIF 的相互作用促进肺癌的增殖和血管生成。
Oncogene. 2013 Feb 28;32(9):1121-34. doi: 10.1038/onc.2012.136. Epub 2012 Apr 23.
4
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.在黑色素瘤中,RAS突变伴随着信号传导从BRAF转换为CRAF以及环磷酸腺苷信号传导的破坏。
Cancer Res. 2006 Oct 1;66(19):9483-91. doi: 10.1158/0008-5472.CAN-05-4227.
5
Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.黑色素瘤细胞对表皮生长因子受体(EGFR)和纤维母细胞生长因子受体(FGFR)激活而非抑制的敏感性受致癌性BRAF和NRAS突变影响。
Pathol Oncol Res. 2015 Sep;21(4):957-68. doi: 10.1007/s12253-015-9916-9. Epub 2015 Mar 9.
6
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.黏膜黑色素瘤中的致癌 BRAF 融合会激活 MAPK 通路,并对 MEK/PI3K 抑制或 MEK/CDK4/6 抑制敏感。
Oncogene. 2017 Jun 8;36(23):3334-3345. doi: 10.1038/onc.2016.486. Epub 2017 Jan 16.
7
Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.肿瘤衍生的纤连蛋白参与黑色素瘤细胞侵袭,并受V600E B-Raf信号通路调控。
J Invest Dermatol. 2007 Feb;127(2):400-10. doi: 10.1038/sj.jid.5700524. Epub 2006 Sep 7.
8
A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.一种黏着斑激酶(FAK)支架抑制剂可破坏FAK和血管内皮生长因子受体-3(VEGFR-3)信号传导,并通过靶向肿瘤细胞和内皮细胞来阻断黑色素瘤的生长。
Cell Cycle. 2014;13(16):2542-53. doi: 10.4161/15384101.2015.941760.
9
TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.转化生长因子β通过BRAF/MEK/ERK和Src/FAK途径诱导甲状腺癌细胞发生上皮-间质转化。
Mol Carcinog. 2016 Nov;55(11):1639-1654. doi: 10.1002/mc.22415. Epub 2015 Sep 21.
10
Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.通过慢病毒介导的RNA干扰使突变型BRAF失活来抑制黑色素瘤的生长和侵袭能力。
Oncogene. 2004 Aug 12;23(36):6031-9. doi: 10.1038/sj.onc.1207812.

引用本文的文献

1
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors.PDE4D 驱动 BRAF 突变型黑色素瘤对 MAPK 抑制剂耐药中的 MAPK 通路重排。
Cell Commun Signal. 2024 Nov 21;22(1):559. doi: 10.1186/s12964-024-01941-y.
2
Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.心脏病理生理学中的纳米域环磷酸腺苷信号传导:开发靶向治疗干预措施的潜力
Physiol Rev. 2025 Apr 1;105(2):541-591. doi: 10.1152/physrev.00013.2024. Epub 2024 Aug 8.
3
Single-cell hdWGCNA reveals metastatic protective macrophages and development of deep learning model in uveal melanoma.

本文引用的文献

1
PARKIN Inactivation Links Parkinson's Disease to Melanoma.PARKIN 失活将帕金森病与黑色素瘤联系起来。
J Natl Cancer Inst. 2015 Dec 17;108(3). doi: 10.1093/jnci/djv340. Print 2016 Mar.
2
Genomic Classification of Cutaneous Melanoma.皮肤黑色素瘤的基因组分类
Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.
3
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.BRAF 和 MEK 联合抑制与单独 BRAF 抑制治疗黑色素瘤。
单细胞 hdWGCNA 揭示转移性保护巨噬细胞和葡萄膜黑素瘤中深度学习模型的发展。
J Transl Med. 2024 Jul 29;22(1):695. doi: 10.1186/s12967-024-05421-2.
4
Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance.具有预后意义的宫颈癌不同免疫代谢亚型的微环境特征分析
Front Genet. 2023 Feb 3;14:1067666. doi: 10.3389/fgene.2023.1067666. eCollection 2023.
5
Integrative QTL mapping and selection signatures in Groningen White Headed cattle inferred from whole-genome sequences.基于全基因组序列推断的格罗宁根白头牛的综合 QTL 图谱和选择信号。
PLoS One. 2022 Oct 26;17(10):e0276309. doi: 10.1371/journal.pone.0276309. eCollection 2022.
6
Is Apremilast a Safe Option in Patients with History of Melanoma? A Case Series and a Review of the Literature.阿普米拉斯对有黑色素瘤病史的患者来说是安全的选择吗?病例系列及文献综述
J Clin Aesthet Dermatol. 2022 Feb;15(2):23-25.
7
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.靶向G蛋白偶联受体及其信号传导作为黑色素瘤的一种治疗选择
Cancers (Basel). 2022 Jan 29;14(3):706. doi: 10.3390/cancers14030706.
8
Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma.磷酸二酯酶4D缺失/抑制在肝细胞癌中发挥抗癌特性。
Cancers (Basel). 2021 May 1;13(9):2182. doi: 10.3390/cancers13092182.
9
Transcriptional co-activator regulates melanocyte differentiation and oncogenesis by integrating cAMP and MAPK/ERK pathways.转录共激活因子通过整合 cAMP 和 MAPK/ERK 通路调节黑素细胞分化和肿瘤发生。
Cell Rep. 2021 May 18;35(7):109136. doi: 10.1016/j.celrep.2021.109136.
10
Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells.阿普米司特通过抑制 PDE4 来减轻皮肤纤维化,其作用机制是直接抑制 M1 和 T 细胞的激活。
Acta Pharmacol Sin. 2022 Feb;43(2):376-386. doi: 10.1038/s41401-021-00656-x. Epub 2021 Apr 13.
N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29.
4
Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology.筛查、早期发现、教育以及黑色素瘤的趋势:现状(2007-2013 年)和未来方向:第一部分。流行病学、高危人群、临床策略和诊断技术。
J Am Acad Dermatol. 2014 Oct;71(4):599.e1-599.e12; quiz 610, 599.e12. doi: 10.1016/j.jaad.2014.05.046.
5
Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.磷酸二酯酶4D抑制剂可限制前列腺癌的生长潜能。
Mol Cancer Res. 2015 Jan;13(1):149-60. doi: 10.1158/1541-7786.MCR-14-0110. Epub 2014 Aug 22.
6
FAK in cancer: mechanistic findings and clinical applications.FAK 在癌症中的作用:机制研究发现与临床应用
Nat Rev Cancer. 2014 Sep;14(9):598-610. doi: 10.1038/nrc3792. Epub 2014 Aug 7.
7
Cyclic AMP (cAMP) signaling in melanocytes and melanoma.黑素细胞和黑色素瘤中的环磷酸腺苷(cAMP)信号传导
Arch Biochem Biophys. 2014 Dec 1;563:22-7. doi: 10.1016/j.abb.2014.07.003. Epub 2014 Jul 10.
8
Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.环磷酸腺苷信号通路在(WT)BRAF/(WT)NRAS 黑色素瘤细胞对维莫非尼敏感性中的突出作用。
Eur J Cancer. 2014 May;50(7):1310-20. doi: 10.1016/j.ejca.2014.01.021. Epub 2014 Feb 19.
9
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.一个黑素细胞谱系程序赋予了对 MAP 激酶通路抑制的抗性。
Nature. 2013 Dec 5;504(7478):138-42. doi: 10.1038/nature12688. Epub 2013 Nov 3.
10
MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells.黑素瘤细胞中 MC1R 和 cAMP 信号抑制 cdc25B 活性并延缓细胞周期进程。
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13845-50. doi: 10.1073/pnas.1201917110. Epub 2013 Aug 1.